Introducing NDI1 or mito-LbNOX, complex I–independent enzymes that convert NADH to NAD+ in the mitochondria, into cancer cells reestablished TCA cycle intermediate labeling in the tumors. The gene discussed is AVPR2; the disease is cancer.